Open Source Securities released a research report on April 10 stating that it gave David Healthcare (300314.SZ) a purchase rating. The main reasons for the rating include: 1) Endoscopy and electrification of staplers are already popular, and the collection policy is expected to increase the penetration rate and localization rate of electric kettles; 2) the subsidiary Vilkady uses the power of harvesting to speed up the release of staplers and forward-looking layout of first aid products. (Mainichi Keizai Shimbun)
开源证券4月10日发布研报称，给予戴维医疗（300314.SZ）买入评级。评级理由主要包括：1）吻合器腔镜化与电动化已是大势，集采政策有望提高电吻渗透率和国产化率；2）子公司维尔凯迪借集采之力加快吻合器放量，前瞻布局急救产品。（每日经济新闻）
Open Source Securities released a research report on April 10 stating that it gave David Healthcare (300314.SZ) a purchase rating. The main reasons for the rating include: 1) Endoscopy and electrification of staplers are already popular, and the collectio
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated